Key Events This Week
27 Jul: Stock opens steady at Rs.60.20 (+0.05%)
28 Jul: Death Cross formation signals bearish trend
28 Jul: Downgrade to Strong Sell by MarketsMOJO
29 Jul: Sharp intraday rally lifts stock to Rs.62.99 (+3.91%)
30-31 Jul: Profit-taking leads to declines, closing at Rs.60.15 (-1.39%)
27 July: Steady Start Despite Sensex Rally
Valiant Laboratories began the week with a modest gain of 0.05%, closing at Rs.60.20 on 27 July. This was in contrast to the Sensex’s robust 1.05% advance to 36,207.16 points. The stock’s low volume of 3,113 shares indicated limited trading interest, reflecting cautious investor positioning ahead of anticipated technical developments.
28 July: Death Cross Formation and Downgrade Trigger Bearish Sentiment
On 28 July, the stock rose 0.70% to Rs.60.62, marginally outperforming the Sensex which slipped 0.14%. However, the day was marked by significant negative news as Valiant Laboratories formed a Death Cross, a key technical indicator where the 50-day moving average crossed below the 200-day moving average. This event signals a potential prolonged bearish trend and weakening momentum.
Simultaneously, MarketsMOJO downgraded the stock from Sell to Strong Sell, citing deteriorating fundamentals and bearish technicals despite recent positive quarterly results. The Mojo Score dropped to 27.0, underscoring the heightened risk profile. These developments overshadowed the slight price gain and set a cautious tone for the remainder of the week.
Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!
- - Accelerating price action
- - Pure momentum play
- - Pre-peak entry opportunity
29 July: Midweek Rally on Volume Uptick
Following the bearish signals, the stock rebounded sharply on 29 July, surging 3.91% to close at Rs.62.99. This was a notable outperformance against the Sensex’s 1.02% gain to 36,524.95. The volume increased to 506 shares, indicating some renewed buying interest possibly driven by short-term traders capitalising on oversold conditions or bargain hunting after the downgrade.
Despite this rally, the broader technical context remained negative, with the Death Cross and other indicators suggesting the upmove could be a temporary correction rather than a trend reversal.
30-31 July: Profit Taking and Declines Amid Bearish Outlook
The final two trading days saw the stock retreat, closing at Rs.61.00 (-3.16%) on 30 July and Rs.60.15 (-1.39%) on 31 July. This decline contrasted with the Sensex’s modest gains of 0.05% and 0.39% respectively, highlighting the stock’s underperformance. Volume on 31 July rose to 1,847 shares, suggesting increased selling pressure as investors digested the bearish technical signals and downgrade.
The stock’s inability to sustain the midweek gains and the persistent negative momentum reflect ongoing concerns about its valuation, financial health, and sector challenges.
Holding Valiant Laboratories Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Weekly Price Performance: Stock vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-07-27 | Rs.60.20 | +0.05% | 36,207.16 | +1.05% |
| 2026-07-28 | Rs.60.62 | +0.70% | 36,155.32 | -0.14% |
| 2026-07-29 | Rs.62.99 | +3.91% | 36,524.95 | +1.02% |
| 2026-07-30 | Rs.61.00 | -3.16% | 36,541.96 | +0.05% |
| 2026-07-31 | Rs.60.15 | -1.39% | 36,684.83 | +0.39% |
Key Takeaways
Bearish Technical Signals: The formation of the Death Cross on 28 July is a significant warning of sustained downward momentum. This was reinforced by bearish MACD, Bollinger Bands, and KST indicators on weekly and monthly charts, signalling a deteriorating trend.
Downgrade to Strong Sell: MarketsMOJO’s downgrade to Strong Sell with a Mojo Score of 27.0 reflects worsening fundamentals and technical outlook, despite the company’s recent quarterly sales and profit growth.
Volatility and Volume: The midweek rally on 29 July was accompanied by a volume increase, suggesting short-term speculative interest. However, the subsequent decline on higher volume indicates profit-taking and cautious sentiment.
Underperformance vs Sensex: The stock’s weekly performance (-0.03%) lagged the Sensex’s 2.39% gain, highlighting relative weakness amid broader market strength.
Valuation and Financial Concerns: Despite a positive quarterly PAT growth of 262.2%, the company’s negative ROE, expensive P/B ratio, and poor debt servicing capacity remain key challenges.
Conclusion
Valiant Laboratories Ltd’s week was characterised by mixed price action overshadowed by bearish technical developments and a significant downgrade. While the stock showed resilience with a sharp midweek rally, the prevailing Death Cross and deteriorating momentum indicators suggest caution. The downgrade to Strong Sell by MarketsMOJO reflects the company’s ongoing fundamental and valuation challenges, despite recent operational improvements. Investors should remain vigilant as the stock navigates a difficult technical and fundamental landscape, with the risk of further downside pressure in the near term.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
